Figure 3From: Red blood cell (RBC) transfusion rates among US chronic dialysis patients during changes to Medicare end-stage renal disease (ESRD) reimbursement systems and erythropoiesis stimulating agent (ESA) labels Monthly percent of chronic dialysis patients with RBC transfusion, base case population stratified by payer. Back to article page